Mark A. Velleca

Companies

• Black Diamond Therapeutics, Inc.Chief executive officer Sep 18, 2023 to now¹
• Black Diamond Therapeutics, Inc.President Sep 18, 2023 to now¹
• Black Diamond Therapeutics, Inc.Board member Aug 11, 2021 to now²
• G1 Therapeutics, Inc.Board member May 16, 2017 to Aug 10, 2023³
• G1 Therapeutics, Inc.Chief executive officer May 16, 2017 to Dec 17, 2020³
• G1 Therapeutics, Inc.President May 16, 2017 to Dec 17, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BDBlack Diamond Therapeutics, Inc. BDTX121,522 shares⁴$220.6K at $1.81Jan 30, 2025
• GTG1 Therapeutics, Inc.116,000 shares⁵Aug 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 30, 2025Granted 75,000 shares of Black Diamond Therapeutics, Inc.⁴
• Sep 15, 2023Granted 5,208 shares at $3.60 of Black Diamond Therapeutics, Inc.⁶
• Aug 8, 2023Sold 2,714 shares at $2.02 of G1 Therapeutics, Inc.⁵
• Aug 8, 2023Exercised options 2,714 shares at $0.30 of G1 Therapeutics, Inc.⁵
• Aug 8, 2023Sold 57,286 shares at $2.00 of G1 Therapeutics, Inc.⁵
• Aug 8, 2023Exercised options 57,286 shares at $0.39 of G1 Therapeutics, Inc.⁵
• Jun 16, 2023Granted 8,929 shares at $2.10 of Black Diamond Therapeutics, Inc.⁷
• Mar 16, 2023Granted 11,228 shares at $1.67 of Black Diamond Therapeutics, Inc.⁸
• Dec 16, 2022Granted 8,424 shares at $1.50 of Black Diamond Therapeutics, Inc.⁹
• Oct 18, 2022Sold 15,000 shares at $11.70 of G1 Therapeutics, Inc.¹⁰
• Oct 18, 2022Exercised options 15,000 shares at $0.39 of G1 Therapeutics, Inc.¹⁰
• Sep 20, 2022Sold 20,000 shares at $13.50 of G1 Therapeutics, Inc.¹¹
• Sep 20, 2022Exercised options 20,000 shares at $0.39 of G1 Therapeutics, Inc.¹¹
• Sep 16, 2022Granted 4,294 shares at $2.62 of Black Diamond Therapeutics, Inc.¹²
• Aug 16, 2022Sold 80,000 shares at $12.64 of G1 Therapeutics, Inc.¹³
• Aug 16, 2022Exercised options 80,000 shares at $0.39 of G1 Therapeutics, Inc.¹³
• Jun 17, 2022Granted 5,542 shares at $2.03 of Black Diamond Therapeutics, Inc.¹⁴
• Mar 18, 2022Granted 2,897 shares at $3.02 of Black Diamond Therapeutics, Inc.¹⁵
• Feb 7, 2022Exercised options 15,000 shares at $0.39 of G1 Therapeutics, Inc.¹⁶
• Nov 9, 2021Exercised options 40,000 shares at $0.39 of G1 Therapeutics, Inc.¹⁷